John W. Walsh Alpha-1 Home Infusion Act of 2025
- Last Action
- 3/25/2025
Actions
- 2025-03-25Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2025-03-25Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2025-03-25Introduced in House
- 2025-03-25Introduced in House
CRS Summary
As of 2025-03-25 (00)
John W. Walsh Alpha-1 Home Infusion Act of 2025
This bill provides for Medicare coverage of treatment for alpha-1 antitrypsin (AAT) deficiency (a protein deficiency that raises the risk of lung and other diseases). Specifically, the bill provides for coverage of at-home augmentation therapy for beneficiaries with emphysema as a result of severe hereditary AAT deficiency. Treatment must be provided through qualified home infusion therapy suppliers; beneficiaries must be under the care of a physician, nurse practitioner, or physician assistant.
Cosponsors (20)
- Chellie Pingree (D-ME)
- Christopher Smith (R-NJ)
- Henry Johnson (D-GA)
- Burgess Owens (R-UT)
- Eleanor Norton (D-DC)
- Young Kim (R-CA)
- David Rouzer (R-NC)
- Paul Tonko (D-NY)
- Timothy Kennedy (D-NY)
- Michael Lawler (R-NY)
- Nicholas Langworthy (R-NY)
- Mikie Sherrill (D-NJ)
- Raul Ruiz (D-CA)
- Angie Craig (D-MN)
- Troy Carter (D-LA)
- William Keating (D-MA)
- Joe Neguse (D-CO)
- Jimmy Panetta (D-CA)
- Thomas Kean (R-NJ)
- Bonnie Watson Coleman (D-NJ)
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.